Clinical and Sociodemographic Barriers to Medication Adherence in Patients with Diabetes: A Cross-Sectional Study in Greece

Giannopoulou X1, Nikolopoulou V2 and Theofilou PORCID Logo*1,3

1School of Social Sciences, Hellenic Open University, Patra, Greece
2Department of Social Administration, Program of Health Services Administration, National School of Public Administration and Local Government, Athens, Greece
3Region of Attica, General Directorate of Public Health and Social Welfare, Athens, Greece

*Corresponding author: Paraskevi Theofilou, School of Social Sciences, Hellenic Open University, Patra, Greece

Received: 23 June 2026; Accepted: 16 July 2026; Published: 24 July 2026

© 2026 The Authors. This is an open-access article and is distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.

Abstract

Background and objective: An interesting issue that needs to be investigated is the effect of physical and mental fatigue on medication adherence in patients with diabetes mellitus. The study aimed to investigate physical and mental fatigue in patients with diabetes mellitus and its relation to medication intake.
Methods: Participants were approached in person at the clinics of the municipality of Drama and in the association of individuals with disabilities of Drama. The data collection tool used in the study was the questionnaire, which included questions regarding the general characteristics of the participants, the fatigue assessment questionnaire – Fatigue Assessment Scale (FAS), and the Self-Efficacy for Appropriate Medication Use Scale (SEAMS). The data collected using the questionnaire were processed and statistically analyzed with the statistical package IBM SPSS Statistics, version 21.
Results: In the sample of patients with diabetes mellitus in the present study, physical fatigue levels were moderate, mental fatigue levels were low (below average), and overall fatigue levels were moderate, while the prevalence of fatigue was very high (75.5%). In addition, higher levels of physical fatigue were also associated with significantly lower levels of self-efficacy for proper medication intake in patients with diabetes mellitus, and vice versa; patients without fatigue were associated with the highest mean levels of self-efficacy for proper medication intake.
Conclusion: There is a moderate association between physical and mental fatigue in patients with diabetes mellitus and its effect on medication intake.

Keywords

diabetes mellitus, physical fatigue, mental fatigue, self-efficacy, medication, adherence

Abbreviations

FAS: Fatigue Assessment Scale, SEAMS: Self-Efficacy for Appropriate Medication Use Scale, SRF-S: Self-Regulatory Fatigue Scale

Introduction

Diabetes mellitus is a progressive metabolic disorder that interferes with the human body’s ability to process and absorb glucose and is currently a significant public health burden [1, 2]. It is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both, the two most common types of diabetes being type I diabetes mellitus and type II diabetes mellitus [3–5].

Self-management is the cornerstone of the overall management of diabetes mellitus and aims for blood glucose levels close to normal in order to reduce the risk of acute blood glucose levels and prevent long-term complications of diabetes [6]. Therefore, continuous self-regulation of blood glucose levels by patients themselves is required, while, at the same time, patients with diabetes mellitus are asked to strictly follow specific instructions, which are mostly related to their diet and physical activity [5, 6].

Although chronic fatigue is a common phenomenon among the general population, patients with diabetes mellitus constitute a subpopulation with a higher probability of experiencing fatigue, tending to present a 2-fold higher frequency of complaints of fatigue compared to individuals without diabetes mellitus [7]. Fatigue, whether physical or mental exhaustion, has been recognized for many years as one of the most frequent and bothersome complaints of patients with diabetes mellitus [8].

Many social, psychological, and physiological factors influence the development and progression of fatigue, while, at the same time, fatigue itself, physical or mental, can also influence a variety of factors [8]. Among the problems caused in particular by fatigue, whether physical or mental, in patients with diabetes are the lack of sufficient concentration, motivation, and energy, as well as the failure to comply with medical instructions and health recommendations due to the lack of willingness to participate in education programs and the necessary participation in self-care programs [7].

Laranjo et al. [9] conducted a study to assess patients’ perceived expectations, barriers and facilitators regarding self-management of type 2 diabetes. The study involved patients with type 2 diabetes who were approached by an outpatient clinic in Portugal, and 3 main issues emerged: glycemic control, physical activity and diet. Difficulties in changing dietary habits were distinguished in 4 main categories: diet plan, food quantity, food quality, and dietary decision-making [9]. Barriers related to physical activity included fatigue, comorbidities, muscle and joint pain, and decision-making. Therefore, fatigue is a significant barrier to patient compliance with physical exercise included in their treatment; however, it did not appear to be a barrier to patient compliance with their diet or glycemic control [9].

The main purpose of the cross-sectional, descriptive study by Park et al. [10] was to assess the mediating effect of diabetes characteristics, such as diabetes symptoms, depression, and diabetes distress, on the relationship between glucose control and fatigue among patients with type 2 diabetes. In patients with A1C levels less than or equal to 7%, fatigue was significantly associated with diabetes symptoms and diabetes distress, but not with glucose levels, either directly or indirectly [10]. In contrast, in patients with A1C levels higher than 7%, fatigue was indirectly associated with glucose levels, and this relationship was mediated by depression, diabetes symptoms, and diabetes distress. Therefore, fatigue is indirectly associated with glycemic control but only in patients with high A1C levels [10].

In the cross-sectional study by Zhao et al. [11], it was examined whether adequate diabetes-related self-care activities are associated with fatigue, anxiety, and perceived stress among patients with type 2 diabetes. This study was conducted in China on a total of 251 patients with type 2 diabetes and showed low levels of anxiety and moderate levels of fatigue, stress, and self-care activities among these patients [11]. High levels of diabetes-related self-care activities, which were found to be influenced by diabetes education, diabetes duration, and high social support, were not significantly associated with fatigue and anxiety, but can reduce perceived stress. Therefore, type 2 diabetes self-care is not significantly associated with fatigue in patients with type 2 diabetes [11].

The cross-sectional association study by Kuo et al. [12] was conducted to examine the relationship between fatigue, factors affecting fatigue, and diabetes self-management, as well as the mediating effect of fatigue on the association between factors and diabetes self-management among adults with type 2 diabetes in Taiwan. Through convenience sampling, 150 patients with type 2 diabetes were recruited, in whom fatigue was assessed with the “Multidimensional Fatigue Inventory” and “Fatigue Symptom Inventory” tools and diabetes self-management with the “Summary of Diabetes Self-Care Activities” tool [12]. Based on the findings, higher levels of fatigue were significantly associated with poorer sleep quality, more depressive symptoms, and a more recent diagnosis of diabetes, while it was also significantly associated with poorer performance in diabetes self-management. In addition, fatigue appeared to mediate the relationship between depressive symptoms, sleep quality, and diabetes self-management. Thus, fatigue may affect diabetes self-management both directly and indirectly, through its mediation of the relationship between psychological factors and diabetes self-management [12].

Wang et al. [13] conducted a cross-sectional study to examine the interaction between self-regulated fatigue, social support, and health-promoting behaviors among patients with type II diabetes mellitus. Fatigue was assessed using the Self-Regulatory Fatigue Scale (SRF-S) tool, and the participants were a total of 316 patients with type II diabetes. According to the findings of this study, social support in patients with type II diabetes mellitus positively predicted health-promoting behaviors, and the main regression coefficients of self-regulated fatigue in these patients were social support and health-promoting behaviors, factors that both showed significant differences. Self-regulated fatigue was found to mediate the relationship between social support and health-promoting behaviors in these patients, with a total effect of 29.28%. Therefore, a significant interaction is observed between self-regulated fatigue, social support, and health-promoting behaviors in patients with type 2 diabetes [13].

The main purpose of this research is to study the physical and mental fatigue of patients with diabetes mellitus and its effect on medication intake.

The specific objectives of this research are as follows:

  • The assessment of physical and mental fatigue in patients with diabetes mellitus.
  • The assessment of self-efficacy in terms of compliance in taking medication in patients with diabetes mellitus.
  • The assessment of the effect of physical and mental fatigue on the self-efficacy of patients with diabetes mellitus in terms of taking medication.
  • The assessment of the effect of general data (gender, age group, etc.) on the self-efficacy of patients in terms of taking medication.

Methods

Participants were approached in person at the clinics of the municipality of Drama and in the association of individuals with disabilities of Drama. Before visiting the above points, communication and verbal and written consent of the responsible persons were obtained. The sampling that was applied was convenience sampling, and the criteria for entry into the study were (1) age over 18 years and (2) diabetes mellitus (regardless of type), while there was no additional exclusion criterion other than age under 18 years and the absence of diabetes mellitus. A total of 90 participants were gathered, while approximately 5% of the individuals initially approached refused to answer, citing lack of time. All participants, when receiving the printed questionnaire, received verbal information about the research topic and the context in which it was conducted, while at the same time they were encouraged to raise any questions they had. The distribution of the questionnaires began in early December 2024 and was completed in late January 2025. Questionnaires were self-administered. This research had the approval of the directors of the public units (approval numbers 916/20.1.2025, 7/30.1.2025). Helsinki Declaration has been followed to involve human subjects in the study.

The data collection tool used in the study was a questionnaire. The questionnaire included questions about the general characteristics of the participants, the Fatigue Assessment Scale (FAS), and the Self-Efficacy for Appropriate Medication Use Scale (SEAMS).

The FAS is a tool for assessing perceived fatigue that includes 10 Likert-type scale questions with 5 possible answers: never, sometimes, regularly, often, always. The total score of the 2 main areas of the tool (physical and mental fatigue) is obtained by summing all the questions and can take values from 10 to 50, with the highest value corresponding to higher levels of fatigue and vice versa [14]. Based on this total score, patients can be distinguished into “patients without fatigue” when the score is less than 22, into “patients with fatigue” when the score is greater than 22, and into “patients with excessive fatigue” when the score is higher than or equal to 35 [15]. Regarding the areas of this scale, the 5 questions of the questionnaire are related to physical fatigue and the other 5 questions to mental fatigue [14]. The FAS tool has been used in many studies in the Greek population, such as in patients with chronic diseases, in patients with rheumatoid arthritis and osteoarthritis, and in patients undergoing hemodialysis, with very good reliability [16]. Its completion in just a few minutes makes this questionnaire a useful tool that can be used by nursing and medical staff to assess fatigue levels [14].

The SEAMS questionnaire is a valid and reliable, short tool that assesses patients’ self-efficacy for medication use. This questionnaire includes 16 questions on a three-point Likert scale that indicate the degree of self-confidence of individuals regarding the correct administration of medications: not at all confident, somewhat confident, and very confident [17]. The SEAMS questionnaire was translated and standardized in Greek by Theofilou [18], where it was found to have high validity and reliability, and the total self-efficacy score is obtained from the sum of the questions, with the lowest possible score being 16 and the highest possible score being 48. Higher values indicate higher self-confidence regarding the correct administration of medication [18].

The data collected using a questionnaire were processed and statistically analyzed with the statistical package IBM SPSS Statistics, version 21. Statistical analysis was divided into descriptive and inferential. In the descriptive analysis, frequencies and percentages were estimated, as well as range, minimum value, maximum value, mean value, and standard deviation. In the inferential analysis, regression analysis, t-test for independent samples, one-way ANOVA, and Spearman correlation were used. The results of the inferential statistical analysis were evaluated at a 95% confidence interval (p value < 0.05).

Results

Cronbach’s alpha was conducted for FAS and SEAMS scales. The results indicated a very good level of reliability for both questionnaires. In particular, physical fatigue presented 0.860, mental fatigue 0.889, and total fatigue 0.854. Moreover, SEAMS items presented values ranging from 0.835 to 0.853.

Regarding the effect size, Pearson correlation was conducted between the relevant variables. The results showed only negative associations, in particular -0.427 between physical fatigue and SEAMS, -0.272 between mental fatigue and SEAMS, and -0.377 between total fatigue and SEAMS.

In the first question of the general data of the questionnaire, participants were asked to state their gender. Based on the results, out of the total of 90 participants, approximately half (52.2%) were female, and 47.8% were male.

In the next question, the patients in the sample were asked to state their age based on specific groups, and approximately half of the participants (48.9%) belonged to the age group of 51 years and older, 35.6% of the patients with diabetes mellitus in the sample were between 31 and 50 years old, while 15.6% of the participants were between 18 and 30 years old.

When asked about their marital status, 37.8% of patients with diabetes mellitus who participated in the survey stated that they were married, 32.2% of patients were single, 18.9% were widowed, and 11.1% were divorced.

From the question regarding the participants’ education, it emerged that most patients with diabetes in the sample (37.1%) had completed secondary education, 28.1% of the participants had completed tertiary education, 21.3% had completed primary education, while 13.5% of the patients had received a master’s degree or doctorate.

In the next question of the questionnaire, respondents were asked to state the type of diabetes they were suffering from. According to the answers recorded, all participants were patients suffering from diabetes mellitus; however, 2/3 of them suffered from type 2 diabetes mellitus and 1/3 of them suffered from type 1 diabetes mellitus (Table 1).

According to the answers recorded to the question regarding when the patients in the sample were diagnosed with diabetes mellitus, the patients participating in this study had been diagnosed with diabetes mellitus from less than a year ago to 50 years ago. The average time of diagnosis of diabetes in the entire sample was equal to 14.87 (±12.82) years (Table 2).

In the last question, participants were asked to indicate the length of time they had been on treatment. Based on the results, treatment for diabetes mellitus in the sample ranged from less than a year to 47 years ago. The average time of treatment for diabetes mellitus in the entire sample was 14.43 (±12.23) years (Table 3).

Overall, the physical fatigue score ranges from 7 to 22, with approximately half of the participants (51.1%) receiving values from 1 to 15, while the mean value of physical fatigue was 15.68 (±4.16). Given that the physical fatigue score is calculated based on 5 questions and can receive values from 5 to 25, it is concluded that the levels of physical fatigue were moderate in the sample of patients with diabetes mellitus in this study.

Correspondingly, the mental fatigue score ranges from 5 to 21, with approximately half of the participants (52.2%) receiving values from 5 to 21, while the mean value of mental fatigue was 12.18 (±3.82). Given that the mental fatigue score is calculated based on 5 questions and can take values from 5 to 25, it is concluded that the levels of mental fatigue were low (below average) in the sample of patients with diabetes mellitus in this study. Overall, the fatigue score was found to take values from 13 to 42, with approximately half of the participants (52.2%) taking values from 13 to 26, while the mean value of total fatigue was 27.86 (±7.47). Given that the fatigue score is calculated based on 10 questions and can take values from 10 to 50, it is concluded that the levels of overall fatigue were moderate in the sample of patients with diabetes mellitus in this study.

From the mapping of the total fatigue score to fatigue levels, half of the patients in the sample (54.4%) experienced fatigue, 24.4% of the patients did not experience fatigue, while 21.1% of the participants were categorized in the group of “patients with excessive fatigue” (Table 4).

Overall, the score of the self-efficacy questionnaire for appropriate medication use ranges from 25 to 44, with approximately half of the participants (53.3%) receiving scores between 25 and 39, while the mean self-efficacy score for appropriate medication use was 38.41 (±5.12). Given that the self-efficacy score for appropriate medication use is calculated based on 16 questions and can range from 16 to 48, it can be concluded that the levels of self-efficacy for appropriate medication use in the sample of patients with diabetes mellitus in this study were relatively high (Table 5).

Higher levels of physical fatigue were associated with lower levels of self-efficacy for taking medication correctly in patients with diabetes mellitus, and vice versa, and these relationships were statistically significant at a 95% confidence interval (p-value = 0.000 < 0.05). Similarly, higher levels of mental fatigue and higher levels of overall fatigue were associated with lower levels of self-efficacy for taking medication correctly in patients with diabetes mellitus, and these relationships were statistically significant at a 95% confidence interval (p-value = 0.010 < 0.05 and p-value = 0.000 < 0.05) (Table 6).

Patients without fatigue were associated with the highest mean levels of self-efficacy for taking medications correctly, and these observed differences between patients with different levels of fatigue in levels of self-efficacy for taking medications correctly were statistically significant at a 95% confidence interval (p-value = 0.000 < 0.05) (Table 7).

Female gender was associated with lower levels of mental fatigue, but with lower mean levels of self-efficacy for taking medication correctly, with higher levels of physical fatigue, and with higher levels of overall fatigue, compared to male gender. However, none of these observed differences between the two genders were statistically significant at a 95% confidence interval (p value > 0.05).

The older age group (51 years and older) was associated with the lowest mean levels of mental fatigue, the middle age group (31 to 50 years) was associated with the highest mean levels of self-efficacy for taking medications correctly and the highest mean levels of mental fatigue, while the younger age group (18 to 30 years) was associated with the highest mean levels of physical fatigue and the highest mean levels of overall fatigue. However, none of these observed differences between ages were statistically significant at a 95% confidence interval (p-value > 0.05).

Widowed patients with diabetes were associated with the highest mean levels of physical fatigue, the highest mean levels of mental fatigue, and the highest mean levels of total fatigue, while married patients with diabetes were associated with the highest mean levels of self-efficacy regarding the correct administration of medications. These observed differences between patients with diabetes with different marital status were statistically significant at a 95% confidence interval for physical fatigue (p-value = 0.023 < 0.05) and for the total fatigue score (p-value = 0.036 < 0.05) (Table 8).

Patients with diabetes mellitus with lower levels of education (primary education) were associated with the highest mean levels of physical fatigue and the highest mean levels of overall fatigue, while patients with diabetes mellitus with higher levels of education (master’s/doctoral) were associated with the highest mean levels of self-efficacy for taking medications correctly and the lowest mean levels of mental fatigue. These observed differences between patients with diabetes mellitus with different levels of education were statistically significant at a 95% confidence interval for physical fatigue (p-value = 0.029 < 0.05) (Table 9).

Patients with type I diabetes mellitus were associated with lower mean levels of self-efficacy for taking medications correctly, higher mean levels of physical fatigue, higher mean levels of mental fatigue, and higher mean levels of total fatigue, compared to patients with type II diabetes mellitus. These observed differences between patients with different types of diabetes mellitus were statistically significant at a 95% confidence interval only for self-efficacy for taking medications correctly (p-value = 0.001 < 0.05), for physical fatigue (p-value = 0.003 < 0.05), for mental fatigue (p-value = 0.001 < 0.05), and for the total fatigue score (p-value = 0.001 < 0.05) (Table 10).

The longer time since the diagnosis of diabetes mellitus for the patients in the sample was associated with higher levels of physical fatigue, mental fatigue and overall fatigue, but with lower levels of self-efficacy regarding the correct taking of medications, and vice versa. However, of these relationships, only the one between the time since the diagnosis of diabetes and the self-efficacy regarding the correct taking of medications was statistically significant at a 95% confidence interval (p-value = 0.024 < 0.05, Correlation coefficient = -0.237), according to which, patients who have more time since the diagnosis of diabetes have lower levels of self-efficacy regarding the correct taking of medications, and vice versa (Table 11).

Patients without fatigue were associated with the lowest mean number of years since diagnosis with diabetes mellitus, compared to patients with fatigue and excessive fatigue who had a higher mean time since diagnosis of diabetes; however, these observed differences were not statistically significant at a 95% confidence interval (p-value = 0.387 > 0.05).

Longer duration of diabetes treatment was associated with higher levels of physical fatigue, mental fatigue, and overall fatigue, but with lower levels of self-efficacy for taking medications correctly, and vice versa. However, of these relationships, only the one between the duration of diabetes treatment and self-efficacy for taking medications correctly was statistically significant at a 95% confidence interval (p-value = 0.011 < 0.05, Correlation coefficient = -0.268), indicating that patients who are treated for diabetes for a longer period of time have lower levels of self-efficacy for taking medications correctly, and vice versa (Table 12).

Patients without fatigue were associated with the lowest mean number of years of diabetes treatment, compared to patients with fatigue and excessive fatigue who had a higher mean time of diabetes treatment, however, these observed differences were not statistically significant at a 95% confidence interval (p-value = 0.466 > 0.05).

Finally, regression analysis was conducted indicating that physical fatigue (Beta -0.493), diabetes type (Beta 0.383), and duration of disease (Beta -0.260) were statistically significant prognostic factors of the SEAMS.

FrequencyPercentValid percentCumulative percent
ValidType 1 diabetes mellitus3033,333,333,3
Type 2 diabetes mellitus6066,766,7100,0
Total90100,0100,0

Table 1: Type of diabetes.

NRangeMinimumMaximumMeanStd. deviation
I was diagnosed with diabetes mellitus before:905005014,8712,819
Valid N (listwise)90

Table 2: Years of diagnosis.

NRangeMinimumMaximumMeanStd. Deviation
I have been undergoing treatment for diabetes mellitus here and:904704714,4312,232
Valid N (listwise)90

Table 3: Years of treatment.

FrequencyPercentValid percentCumulative percent
ValidPatients without fatigue2224,424,424,4
Patients with fatigue4954,454,478,9
Patients with excessive fatigue1921,121,1100,0
Total90100,0100,0

Table 4: Levels of fatigue.

NRangeMinimumMaximumMeanStd. deviation
Self-efficacy of proper medication intake9019254438,415,123
Valid N (listwise)90

Table 5: Self-efficacy of proper medication intake.

Physical fatigueMental fatigueTotal fatigue score
Self-efficacy of proper medication intakePearson correlation-,427**-,272**-,377**
Sig. (2-tailed),000,010,000
N909090
**Correlation is significant at the 0.01 level (2-tailed).

Table 6: Correlations among variables.

Self-efficacy of proper medication intake
NMeanStd. deviationStd. ErrorMinimumMaximum
Patients without fatigue2240,092,991,6383244
Patients with fatigue4939,185,044,7212544
Patients with excessive fatigue1934,475,4811,2572643
Total9038,415,123,5402544

ANOVA

Self-efficacy of proper medication intake
Sum of squaresdfMean squareFSig.
Between groups385,8872192,9438,609,000
Within groups1949,9028722,413
Total2335,78989

Table 7: Self-efficacy of proper medication intake in different levels of fatigue.

NMeanStd. deviationStd. errorMinimumMaximum
Self-efficacy of proper medication intakeUnmarried2938,003,937,7312944
Married3439,244,000,6862944
Divorced1036,008,7182,7572544
Widower(s)1738,886,1231,4852644
Total9038,415,123,5402544
Physical fatigueUnmarried2915,974,648,863722
Married3414,623,758,644822
Divorced1014,304,6921,4841021
Widower(s)1718,122,643,6411422
Total9015,684,162,439722
Mental fatigueUnmarried2912,934,605,855621
Married3410,883,812,654520
Divorced1012,302,003,633916
Widower(s)1713,412,373,5761120
Total9012,183,821,403521
Total fatigue scoreUnmarried2928,908,9021,6531342
Married3425,506,9901,1991342
Divorced1026,606,1321,9391937
Widower(s)1731,534,5021,0922540
Total9027,867,465,7871342

ANOVA

Sum of squaresdfMean squareFSig.
Self-efficacy of proper medication intakeBetween groups89,907329,9691,148,335
Within groups2245,8828626,115
Total2335,78989
Physical fatigueBetween groups160,796353,5993,338,023
Within groups1380,8608616,057
Total1541,65689
Mental fatigueBetween groups99,546333,1822,379,075
Within groups1199,6098613,949
Total1299,15689
Total fatigue scoreBetween groups465,2973155,0992,968,036
Within groups4493,8258652,254
Total4959,12289

Table 8: Self-efficacy of proper medication intake and fatigue in different levels of marital status.

NMeanStd. deviationStd. errorMinimumMaximum
Self-efficacy of proper medication intakePrimary1938,325,5681,2772644
Secondary3338,736,0221,0482544
Tertiary2537,644,405,8812544
Master’s / PhD1239,672,934,8473444
Total8938,465,130,5442544
Physical fatiguePrimary1917,583,271,750822
Secondary3315,093,987,694822
Tertiary2516,244,585,917722
Master’s / PhD1213,333,9851,150921
Total8915,714,176,443722
Mental fatiguePrimary1913,003,367,772520
Secondary3311,362,498,435718
Tertiary2513,245,5321,106621
Master’s / PhD1211,082,678,773816
Total8912,203,835,407521
Total fatigue scorePrimary1930,586,3451,4561340
Secondary3326,455,9691,0391639
Tertiary2529,489,6661,9331342
Master’s / PhD1224,426,1421,7731735
Total8927,917,489,7941342
ANOVA
Sum of squaresdfMean squareFSig.
Self-efficacy of proper medication intakeBetween groups37,035312,345,460,711
Within groups2279,0778526,813
Total2316,11288
Physical fatigueBetween groups153,819351,2733,157,029
Within groups1380,5868516,242
Total1534,40488
Mental fatigueBetween groups77,247325,7491,798,154
Within groups1217,1138514,319
Total1294,36088
Total fatigue scoreBetween groups413,3113137,7702,590,058
Within groups4521,9708553,200
Total4935,28188

Table 9: Self-efficacy of proper medication intake and fatigue in different levels of education.

I am a patient:NMeanStd. deviationStd. error mean
Self-efficacy of proper medication intakeType 1 diabetes mellitus3035,934,806,877
Type 2 diabetes mellitus6039,654,853,627
Physical fatigueType 1 diabetes mellitus3017,474,167,761
Type 2 diabetes mellitus6014,783,893,503
Mental fatigueType 1 diabetes mellitus3014,374,522,826
Type 2 diabetes mellitus6011,082,884,372
Total fatigue scoreType 1 diabetes mellitus3031,838,3301,521
Type 2 diabetes mellitus6025,876,155,795
Independent samples test
Levene’s test for equality of variancest-test for equality of means
FSig.tdfSig. (2-tailed)Mean differenceStd. error difference
Self-efficacy of proper medication intakeEqual variances assumed,136,714-3,43688,001-3,7171,082
Equal variances not assumed-3,44758,619,001-3,7171,078
Physical fatigueEqual variances assumed,575,4503,01188,0032,683,891
Equal variances not assumed2,94354,717,0052,683,912
Mental fatigueEqual variances assumed18,601,0004,18588,0003,283,785
Equal variances not assumed3,62541,156,0013,283,906
Total fatigue scoreEqual variances assumed7,494,0073,84188,0005,9671,553
Equal variances not assumed3,47745,3335,9671,716

Table 10: Self-efficacy of proper medication intake and fatigue in different type of diabetes.

I was diagnosed with diabetes mellitus before:
Self-efficacy of proper medication intakePearson correlation-,237*
Sig. (2-tailed),024
N90
Physical fatiguePearson correlation,044
Sig. (2-tailed),678
N90
Mental fatiguePearson correlation,035
Sig. (2-tailed),744
N90
Total fatigue scorePearson correlation,043
Sig. (2-tailed),690
N90
*Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.01 level (2-tailed).

Table 11: Correlations among variables.

I have been undergoing treatment for diabetes mellitus here and:
Self-efficacy of proper medication intakePearson correlation-,268*
Sig. (2-tailed),011
N90
Physical fatiguePearson correlation,048
Sig. (2-tailed),653
N90
Mental fatiguePearson correlation,039
Sig. (2-tailed),712
N90
Total fatigue scorePearson correlation,047
Sig. (2-tailed),660
N90
*Correlation is significant at the 0.05 level (2-tailed).
**Correlation is significant at the 0.01 level (2-tailed).

Table 12: Correlations among variables.

Discussion

In addition to increased mortality, diabetes mellitus can lead to poor physical and mental health [2]. Complications of diabetes mellitus are related to various body systems, such as the eyes, kidneys, and cardiovascular system, while chronic ulcers associated with diabetes (diabetic ulcers) are also common, often leading to amputation of the lower extremities [19]. A common complication of diabetes mellitus is fatigue, both physical and/or mental. Although chronic fatigue is a common phenomenon among the general population, patients with diabetes mellitus constitute a subpopulation with a higher probability of experiencing fatigue, tending to present a 2-fold higher frequency of complaints of fatigue compared to people without diabetes [7]. Indeed, fatigue, whether physical or mental, has been recognized for many years as one of the most frequent and bothersome complaints of patients with diabetes mellitus [8].

Many social, psychological, and physiological factors influence the development and progression of fatigue, while, at the same time, fatigue itself, whether physical or mental, can also be associated with various factors, such as quality of life and compliance with treatment [8, 12]. In order to avoid short-term and long-term complications of diabetes, self-management is necessary, and for this reason, it is important to ensure full compliance of patients with their medication and with all instructions they receive from their attending physician [6]. In this context, it is important to investigate the possible relation of physical or mental fatigue to the compliance of patients with diabetes mellitus with their treatment.

Based on the above, an interesting issue that needs to be investigated is the effect of physical and mental fatigue on medication adherence. However, in the recent international literature, no primary study was identified that examined the relationship between physical and mental fatigue and medication adherence in parallel. Therefore, the main purpose of this research was to study physical and mental fatigue in patients with diabetes mellitus and its effect on medication adherence.

Overall, in the sample of patients with diabetes mellitus in the present study, physical fatigue levels were moderate, mental fatigue levels were low (below average), and overall fatigue levels were moderate. The mean FAS value in the total sample was equal to 27.86 (±7.47), a value that is fully consistent with the mean FAS value obtained in another sample of patients with type II diabetes mellitus in Greece (27 (±7.63)) [14]. In contrast, in another study, the average levels of fatigue were relatively high [20]. Overall, the prevalence of fatigue among patients with diabetes mellitus ranges between 23% and 50% in the international literature [8]; however, in the present study, this prevalence was much higher (75.5%). This high percentage is consistent with the conclusions of the study by Christian et al. [21], which highlighted the high levels of fatigue among patients with diabetes mellitus [21].

In addition to fatigue, in the present study, the levels of self-efficacy regarding the correct intake of medication among patients with diabetes mellitus were also assessed. Achieving and maintaining optimal glycemic control through appropriate medication is an important goal of diabetes treatment [22]. In the present study, self-efficacy levels regarding the correct use of medications in the sample of patients with diabetes were relatively high. Non-adherence to medication has been recognized as a serious problem in the management of patients with diabetes, as only 45% of patients with diabetes are able to maintain glycemic control during their treatment [17].

A very important research question of the present study was whether physical and mental fatigue is related to self-efficacy for proper medication use. In the sample of patients with diabetes mellitus in the present study, it was found that higher levels of physical fatigue were associated with significantly lower levels of self-efficacy for proper medication use in patients with diabetes mellitus, and vice versa; patients without fatigue were associated with the highest mean levels of self-efficacy for proper medication use. Uncontrolled diabetes mellitus and poor diabetes self-management have also been identified in other studies as a key factor associated with fatigue [12], a fact confirmed in the present study. This can be explained by the fact that patients with diabetes fatigue syndrome face many mental and physical challenges and often experience burnout due to diabetes treatment, which can lead patients to neglect their treatment. This results in the deterioration of their health status and their entry into a state of unregulated treatment [4]. Thus, both physical and mental fatigue can reduce and compromise patients’ compliance with diabetes treatment [1]. However, in other studies, fatigue was not significantly associated with diabetes self-care at all [11], was found to be a significant barrier to patient compliance only with physical exercise and not with their medication [9], or was indirectly associated with glycemic control but only in patients with high A1C levels [10].

From the results of the inductive statistical analysis between the various general elements and the levels of fatigue and self-efficacy regarding medication use, various significant relationships were identified. Initially, widowed patients with diabetes mellitus were associated with higher mean levels of physical fatigue and higher mean levels of overall fatigue. Patients with diabetes mellitus with lower levels of education (primary education) were associated with higher mean levels of physical fatigue, while patients with type I diabetes mellitus were associated with significantly lower mean levels of self-efficacy for taking medication correctly, higher mean levels of physical fatigue, higher mean levels of mental fatigue, and higher mean levels of overall fatigue, compared to patients with type II diabetes mellitus.

Patients who have had diabetes for longer have significantly lower levels of self-efficacy for taking medication correctly, and vice versa; patients who have been treated for diabetes for longer also have significantly lower levels of self-efficacy for taking medication correctly, and vice versa. This finding seems somewhat paradoxical, as patients with longer duration of diabetes and longer duration of diabetes treatment would be expected to have greater experience with medication, and therefore, to exhibit higher levels of self-efficacy in taking their medication correctly. However, maybe it is not necessarily paradoxical, and some possible explanations may include treatment fatigue, burnout, complication burden, or ageing effects.

Furthermore, no significant association was observed between fatigue and time since diagnosis of diabetes, a finding that contradicts that of another study, where higher levels of fatigue were significantly associated with a more recent diabetes diagnosis [12].

In contrast, gender and age group were not found to be significantly correlated to fatigue levels in patients with diabetes, a finding that is in complete contrast to other studies, where gender and age emerged as the most important factors shaping fatigue levels [8]. Also, gender and age were not statistically significantly associated with self-efficacy regarding the correct use of medications.

Key limitations of this research include the sampling method, which was convenience sampling, and the relatively small sample of patients with diabetes that was collected. Further, the observed association between fatigue and self-efficacy may be confounded. For example, depression could independently increase fatigue and reduce self-efficacy. Consequently, future studies may be conducted using numerous factors. Nevertheless, there are some strengths. The topic of the present study is relevant and clinically important, addressing an underexplored area in Greek populations with diabetes, the use of established instruments (FAS and SEAMS), while the objectives are clearly stated.

Conclusion

Based on all of the above, it is recommended that the levels of physical and mental fatigue of all patients with diabetes be examined during their medical follow-up, especially patients with type 1 diabetes who tend to have higher levels of fatigue, and that health professionals provide ways to deal with fatigue. Given that fatigue was significantly associated with self-efficacy for proper medication administration, this more effective management of fatigue will contribute to increasing their effectiveness in properly taking their medications, and subsequently, to better diabetes management and patient outcomes.

Author's Contribution

Conception and design, supervision, visualization, manuscript review and editing (Giannopoulou X, Theofilou P), data collection, analysis, drafting of the original manuscript (Giannopoulou X, Theofilou P), drafting and critical revision of the manuscript (Giannopoulou X, Theofilou P), drafting of the original manuscript and figure preparation (Giannopoulou X, Nikolopoulou V, Theofilou P), supervision, visualization, manuscript writing, review, and editing (Giannopoulou X, Theofilou P).

Funding

None.

Acknowledgments

The authors would like to thank the patients for their participation in the present study.

Data Sharing Statement

Data related to this research can be found within this article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Abbas Q, Latif S, Ayaz HH, et al. Cognitive behavior therapy for diabetes distress, depression, health anxiety, quality of life and treatment adherence among patients with type-II diabetes mellitus: a randomized control trial. BMC Psychiatry. 2023;23(86).
  2. Mishra R, Sharma SK, Verma R, et al. Medication adherence and quality of life among type-2 diabetes mellitus patients in India. 2021;12(10):1740-49.
  3. Bhatt PP, Sheth MS. Comparison of fatigue and functional status in elderly type 2 diabetes patients versus age and gender matched individuals. Aging Med. 2024;7(1):84-89.
  4. Kusnanto K, Pradipta RO, Arifin H, et al. What I felt as a diabetes fatigue survivor: a phenomenology study. J Diabetes Metab Disord. 2022;21:1753–62.
  5. Quattrin T, Mastrandrea LD, Walker LSK. Type 1 diabetes. The Lancet. 2023;401(10394): 2149-62.
  6. Muijs LT, de Wit M, Knoop H, et al. Feasibility and user experience of the unguided web-based self-help app ‘MyDiaMate’ aimed to prevent and reduce psychological distress and fatigue in adults with diabetes. Internet Interv. 2021;25:100414.
  7. Vard N, Abedi HA and Amini M. A Review of Fatigue Condition in Patients with Type II Diabetes in Isfahan Endocrine and Metabolism Research Center. 2016.
  8. Nguyen C, Parson HK, Pettaway J, et al. Utilizing a quality of life tool to examine the presence of fatigue in subjects with diabetes mellitus. J Clin Transl Endocrinol. 2023;34:100328.
  9. Laranjo L, Neves AL, Costa A, et al. Facilitators, barriers and expectations in the self-management of type 2 diabetes-a qualitative study from Portugal. Eur J Gen Pract. 2015;21(2):103-10.
  10. Park H, Park C, Quinn L, et al. Glucose control and fatigue in type 2 diabetes: the mediating roles of diabetes symptoms and distress. J Adv Nurs. 2015;71(7):1650-60.
  11. Zhao FF, Suhonen R, Katajisto J, et al. The association of diabetes-related self-care activities with perceived stress, anxiety, and fatigue: a cross-sectional study. Patient Prefer Adherence. 2018;12:1677-86.
  12. Kuo HJ, García AA, Huang YC, et al. Impact of Fatigue and Its Influencing Factors on Diabetes Self-Management in Adults with Type 2 Diabetes: A Structural Equation Modeling Analysis. Sci Diabetes Self Manag Care. 2023;49(6):438-448.
  13. Wang X, Zhang F, Ge Y, et al. The associations between social support, self-regulatory fatigue, and health-promoting behaviors among people with type 2 diabetes mellitus: a cross-sectional survey. Front Public Health. 2023;11:1281065.
  14. Vasilaki M, Vlachou E, Kavga A, et al. Fatigue among Patients with Type 2 Diabetes Mellitus: The Impact of Spirituality and Illness Perceptions. Healthcare (Basel). 2023;11(24):3154.
  15. Zyga S, Alikari V, Sachlas A, et al. Assessment of Fatigue in End Stage Renal Disease Patients Undergoing Hemodialysis: Prevalence and Associated Factors. Med Arch. 2015;69(6):376-80.
  16. Alikari V, Sachlas A, Giatrakou S, et al. Fatigue in Arthritis: A Multidimensional Phenomenon with Impact on Quality of Life:Fatigue and Quality of Life in Arthritis. Adv Exp Med Biol. 2017;987:243-56.
  17. Wu J, Tao Z, Song Z, et al. Validation and psychometric properties of the self-efficacy for Appropriate Medication Use Scale in elderly Chinese patients. Int J Clin Pharm. 2021;43(3):586-594.
  18. Theofilou P. Self-Efficacy for Appropriate Medication Use Scale (SEAMS): translation and cultural adaptation in Greece. Series Clin Med Case Rep Rev. 2023;1(3):1-4.
  19. Hamid YH, Mohammed M, Hamid S, et al. Impact of Diabetic Foot Ulcer on the Health-Related Quality of Life of Diabetic Patients in Khartoum State. Cureus. 2024;16(1):e52813.
  20. Su SF, Yeh WT. Fatigue and Quality of Life Among Patients with Diabetes and Non-diabetes Receiving Primary Percutaneous Coronary Interventions. Asian Nurs Res (Korean Soc Nurs Sci). 2023;17(2):83-90.
  21. Christian A, Nagar K. Understanding Patients Experiences Living with Diabetes Mellitus: A Qualitative Study, Gujarat, India. J Pharm Res Int. 2021;33(58A):464-471.
  22. Deshmane AR, Muley A. Quality of Life and Its Association with Time in Range Among People with Type 2 Diabetes Mellitus Following Different Dietary Interventions: A Crossover Clinical Trial. Cureus. 2024;16(4):e57624.